Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
B

BDX

NYSE

BECTON DICKINSON & CO

Latest disclosureSeptember 29, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 12 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 29

Limited filing history
All29Buying0Selling12Other17
Filters

Last 30 daysNo qualifying insider buying. Sales: $13.96K by 1 insider.

12 of 29 trades · March 26, 2026 – September 28, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 12 trades on this page.

Sale disclosed

Michael Feld

EVP, Chief Revenue Officer

Common Stock

Reported value
$13.96K
Reported price
$183.70 / share
Traded September 28, 2026Filed September 29, 2026SEC filing
Sale disclosed

Michael Feld

EVP, Chief Revenue Officer

Common Stock

Reported value
$31.1K
Reported price
$188.49 / share
Traded August 26, 2026Filed August 27, 2026SEC filing
Sale disclosed

Thomas E. Polen Jr

Chairman, CEO and President

Common Stock

Reported value
$768.12K
Reported price
$185.00 / share
Traded August 13, 2026Filed August 14, 2026SEC filing
Sale disclosed

Roland Goette

EVP and President, EMEA

Common Stock

Reported value
$440.89K
Reported price
$180.84 / share
Traded August 11, 2026Filed August 12, 2026SEC filing
Sale disclosed

Michael Feld

EVP, Chief Revenue Officer

Common Stock

Reported value
$11.78K
Reported price
$157.13 / share
Traded July 27, 2026Filed July 28, 2026SEC filing
Sale disclosed

Michael Feld

EVP, Chief Revenue Officer

Common Stock

Reported value
$11.46K
Reported price
$152.80 / share
Traded June 26, 2026Filed June 26, 2026SEC filing
Sale disclosed

Michael David Garrison

EVP & Pres Med.Essntl&BioPharm

Common Stock

Reported value
$160.23K
Reported price
$145.66 / share
Traded June 24, 2026Filed June 25, 2026SEC filing
Sale disclosed

Michael David Garrison

EVP & Pres Med.Essntl&BioPharm

Common Stock

Reported value
$166.63K
Reported price
$151.48 / share
Traded June 10, 2026Filed June 11, 2026SEC filing
Sale disclosed

Thomas E. Polen Jr

Chairman, CEO and President

Common Stock

Reported value
$404.51K
Reported price
$146.35 / share
Traded June 1, 2026Filed June 3, 2026SEC filing
Sale disclosed

Michael Feld

EVP, Chief Revenue Officer

Common Stock

Reported value
$11.05K
Reported price
$147.35 / share
Traded May 26, 2026Filed May 27, 2026SEC filing
Sale disclosed

Michael Feld

EVP, Chief Revenue Officer

Common Stock

Reported value
$11.24K
Reported price
$151.94 / share
Traded April 27, 2026Filed April 28, 2026SEC filing
Sale disclosed

Michael Feld

EVP, Chief Revenue Officer

Common Stock

Reported value
$11.76K
Reported price
$156.83 / share
Traded March 26, 2026Filed March 27, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
EVP, Chief Revenue OfficerCommon StockSale10b5-176$183.70 / share$13.96KSep 28Filed Sep 29 · 1d laterSEC filing
EVP, Chief Revenue OfficerCommon StockSale10b5-1165$188.49 / share$31.1KAug 26Filed Aug 27 · 1d laterSEC filing
Chairman, CEO and PresidentCommon StockSale10b5-14,152$185.00 / share$768.12KAug 13Filed Aug 14 · 1d laterSEC filing
EVP and President, EMEACommon StockSale2,438$180.84 / share$440.89KAug 11Filed Aug 12 · 1d laterSEC filing
EVP, Chief Revenue OfficerCommon StockSale10b5-175$157.13 / share$11.78KJul 27Filed Jul 28 · 1d laterSEC filing
EVP, Chief Revenue OfficerCommon StockSale10b5-175$152.80 / share$11.46KJun 26Filed Jun 26 · 0d laterSEC filing
EVP & Pres Med.Essntl&BioPharmCommon StockSale10b5-11,100$145.66 / share$160.23KJun 24Filed Jun 25 · 1d laterSEC filing
EVP & Pres Med.Essntl&BioPharmCommon StockSale10b5-11,100$151.48 / share$166.63KJun 10Filed Jun 11 · 1d laterSEC filing
Chairman, CEO and PresidentCommon StockSale10b5-12,764$146.35 / share$404.51KJun 1Filed Jun 3 · 2d laterSEC filing
EVP, Chief Revenue OfficerCommon StockSale10b5-175$147.35 / share$11.05KMay 26Filed May 27 · 1d laterSEC filing
EVP, Chief Revenue OfficerCommon StockSale10b5-174$151.94 / share$11.24KApr 27Filed Apr 28 · 1d laterSEC filing
EVP, Chief Revenue OfficerCommon StockSale10b5-175$156.83 / share$11.76KMar 26Filed Mar 27 · 1d laterSEC filing

Congress transactions 3

All Congress filings
Purchase disclosed

Becton, Dickinson and Company Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
March 27, 2026
Filed July 21, 2026 · 116d laterOriginal report
Sale disclosed

Becton, Dickinson and Company Common Stock (BDX) · Stock

The filing reports a sale for the member.

Thomas H. Kean Jr official portraitThomas H. Kean JrReporting House member
Reported amount
$1,001 – $15,000Reported range; exact amount not disclosed.
Trade date
May 21, 2026
Filed June 18, 2026 · 28d laterOriginal report
Sale disclosed

Becton, Dickinson and Company Common Stock (BDX) · Stock

The filing reports a sale for a joint account.

Kevin Hern official portraitKevin HernReporting House member
Reported amount
$15,001 – $50,000Reported range; exact amount not disclosed.
Trade date
March 17, 2026
Filed April 3, 2026 · 17d laterOriginal report
Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0000010795
Latest public acceptance
Sep 30, 2026, 01:13 AM UTC
Score calculated
Oct 8, 2026, 12:03 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.